Efficacy and Safety of Bevacizumab for the Treatment of Advanced Hepatocellular Carcinoma: A Systematic Review of Phase II Trials
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy and Safety of Bevacizumab for the Treatment of Advanced Hepatocellular Carcinoma: A Systematic Review of Phase II Trials
Authors
Keywords
-
Journal
PLoS One
Volume 7, Issue 12, Pages e49717
Publisher
Public Library of Science (PLoS)
Online
2012-12-20
DOI
10.1371/journal.pone.0049717
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anti-angiogenesis therapy in cancer: Current challenges and future perspectives
- (2012) Farbod Shojaei CANCER LETTERS
- Hepatocellular carcinoma
- (2012) Alejandro Forner et al. LANCET
- Efficacy of Bevacizumab plus Erlotinib for Advanced Hepatocellular Carcinoma and Predictors of Outcome: Final Results of a Phase II Trial
- (2012) A.O. Kaseb et al. ONCOLOGY
- Targeted systemic therapies for hepatocellular carcinoma: Clinical perspectives, challenges and implications
- (2012) Catherine Frenette WORLD JOURNAL OF GASTROENTEROLOGY
- Phase 2 trial of bevacizumab, capecitabine, and oxaliplatin in treatment of advanced hepatocellular carcinoma
- (2011) Weijing Sun et al. CANCER
- Phase 2 study of bevacizumab plus erlotinib in patients with advanced hepatocellular cancer
- (2011) Philip A. Philip et al. CANCER
- Asian Consensus Workshop Report: Expert Consensus Guideline for the Management of Intermediate and Advanced Hepatocellular Carcinoma in Asia
- (2011) Kwang-Hyub Han et al. ONCOLOGY
- Signaling Pathways in Hepatocellular Carcinoma
- (2011) Daniela Sia et al. ONCOLOGY
- Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma
- (2010) C-H Hsu et al. BRITISH JOURNAL OF CANCER
- Bevacizumab toxicities and their management in ovarian cancer
- (2010) Leslie M. Randall et al. GYNECOLOGIC ONCOLOGY
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
- (2010) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Current approach in the treatment of hepatocellular carcinoma
- (2010) Luigi Rossi World Journal of Gastrointestinal Oncology
- Acute and long-term gastrointestinal consequences of chemotherapy
- (2009) Frédéric Di Fiore et al. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- Phase II Trial of the Combination of Bevacizumab and Erlotinib in Patients Who Have Advanced Hepatocellular Carcinoma
- (2009) Melanie B. Thomas et al. JOURNAL OF CLINICAL ONCOLOGY
- Progression-free survival and time to progression as primary end points in advanced breast cancer: often used, sometimes loosely defined
- (2008) E. D. Saad et al. ANNALS OF ONCOLOGY
- Phase II Trial Evaluating the Clinical and Biologic Effects of Bevacizumab in Unresectable Hepatocellular Carcinoma
- (2008) Abby B. Siegel et al. JOURNAL OF CLINICAL ONCOLOGY
- Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. JNCI-Journal of the National Cancer Institute
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More